---
$id: https://graph.org.ai/products/commodity/51432804
$type: Product
source: UNSPSC
code: "51432804"
title: "Enalaprilat"
class: "51432800"
classTitle: "Antihypertensive oligopeptides"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enalaprilat

**UNSPSC Code**: 51432804
**Class**: [Antihypertensive oligopeptides](Antihypertensive oligopeptides.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor with the molecular formula C18H24N2O5.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GV0O7ES0R3, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but generally known as enalaprilat, which bears US NIH Compound Identifier 5362032. European Medicines Agency schedules Enalaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06515MIG. ENALAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enalaprilat under HS 29339990 and SITC 51577. As of Q4 2014, ENALAPRILAT remains the US FDA Preferred Term for this commodity. Enalaprilat bears US NLM identifiers UMLS ID C0014027 and NCI Concept Code C47510. SMILES: O=C(N1C(CCC1)C(=O)O)C(NC(CCC1CCCCC1)C(=O)OCC)C.

